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Background: Placental mesenchymal dysplasia (PMD) is a
distinct syndrome of unknown aetiology that is associated
with significant fetal morbidity and mortality. Intrauterine
growth restriction is common, yet, paradoxically, many of the
associated fetuses/newborns have been diagnosed with
Beckwith-Wiedemann syndrome (BWS).
Methods: We report two cases of PMD with high levels of
androgenetic (complete paternal uniparental isodisomy) cells
in the placenta and document, in one case, a likely
androgenetic contribution to the fetus as well.
Results: The same haploid paternal complement found in the
androgenetic cells was present in coexisting biparental cells,
suggesting origin from a single fertilisation event.
Conclusions: Preferential allocation of the normal cells into
the trophoblast explains the absence of trophoblast over-
growth, a key feature of this syndrome. Interestingly, the
distribution of androgenetic cells appears to differ from that
reported for artificially created androgenetic mouse chi-
meras. Androgenetic mosaicism for the first time provides an
aetiology for PMD, and may be a novel mechanism for BWS
and unexplained intrauterine growth restriction.
A
ndrogenetic (paternal only) development is observed in
about 1/800 human pregnancies in the form of
complete hydatidiform moles (CHMs).1 These embryos
can implant in the uterus and are associated with cystic
oedematous chorionic villi (fluid accumulation within the
placental villi), trophoblastic hyperplasia (overgrowth of the
outer layer of the villi), and generally absent fetal develop-
ment. About 75% of CHMs are thought to arise from
fertilisation of an anucleate egg by a single haploid sperm,
which subsequently undergoes endoreduplication, while
most of the remaining cases involve fertilisation by two
sperm. Their abnormal growth is attributed to the parent-of-
origin dependent expression (imprinting) of a number of
developmentally important genes.2 3 Partial hydatidiform
moles (PHMs), which are due to triploidy, show some
phenotypic overlap with CHMs. However, PHMs exhibit a
range of villi from normal to cystic with focal trophoblastic
hyperplasia. Furthermore, development of an abnormal fetus
is often seen in PHM.4
Placental mesenchymal dysplasia (PMD) is a distinct
placental phenotype that has often been misdiagnosed as a
PHM and therefore has also been referred to as a ‘‘pseudo
partial mole’’.5–9 Placentas with PMD are typically larger than
average and show cystic areas on ultrasound but can co-exist
with a completely normal fetus; however, intrauterine
growth restriction and fetal or neonatal death are common.
A key feature that distinguishes PMD from a partial or
complete mole is the absence of trophoblast hyperplasia.
Furthermore, whereas partial moles are triploid, most
reported cases of PMD have a normal female 46,XX
karyotype. Although an aetiology for PMD has not been
shown, the preponderance of females has raised the
suspicion of involvement of an X linked gene.10 In about
one third of cases, PMD is associated with fetuses exhibiting
features of Beckwith-Wiedemann syndrome (BWS), includ-
ing omphalocele, macroglossia, and visceromegaly.6 8 9 BWS
generally results from abnormal expression of imprinted
genes on 11p15.5 by one of several mechanisms and, thus,
the abnormal expression of imprinted genes has also been
raised as a possible aetiology for PMD.9
In this report, we present two pregnancies affected by PMD
in which androgenetic/biparental whole genome mosaicism
was observed. The phenotypic features of PMD, including
absence of trophoblastic hyperplasia, association with BWS,
and preponderance of females, can all be explained by this
novel mechanism. Such pregnancies also offer a rare
opportunity to consider the imprinting effects associated




A 38 year old woman was referred for amniocentesis with a
twin pregnancy at 16 weeks gestation because of increased
maternal age. An ultrasound examination revealed a normal
placenta in twin 1B, but twin 1A, the smaller twin, had a
placenta that was described as cystic and enlarged, with a
‘‘moth eaten’’ appearance. Throughout gestation, the growth
of twin 1A continued to lag behind that of twin 1B (36th and
22nd centiles at 28 and 32 weeks gestation, respectively) and
liver cysts were noted at 28 weeks. These liver cysts
continued to enlarge, eventually encroaching upon the heart,
and in utero fetal death was noted at 34 weeks gestation. At
this time twin 1B, who showed normal growth and
development throughout gestation (58th centile), was
delivered. Postnatal development of twin 1B has since been
normal. The parents declined an autopsy of twin 1A,
therefore further details on the liver cysts seen on ultrasound
are unavailable.
Gross placental examination of case 1 revealed a dichor-
ionic twin placenta with fused placental discs. The placental
weight was heavy, at 1900 g. The gross and histological
features of twin 1B appeared normal. Macroscopically, the
twin 1A placental plate contained several large cystic
structures, up to 1 cm in size admixed with adherent friable
chorionic villi (supplementary figure 1). Microscopic sections
demonstrated marked stem villus hydrops with surrounding
Abbreviations: BWS, Beckwith-Wiedemann syndrome; CGH,
comparative genomic hybridisation; CHM, complete hydatidiform mole;
FISH, fluorescence in situ hybridisation; PMD, placental mesenchymal
dysplasia; PHM, partial hydatidiform mole; UPiD, uniparental isodisomy
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unremarkable small terminal villi. Subchorionic aneurysmal
stem villus vessels and nucleated fetal red blood cells were
also identified. No trophoblastic proliferation was present.
DNA ploidy studies revealed a diploid population with a
minor (,20%) tetraploid population. The histological fea-
tures were those of PMD.
Case 2
A second trimester triple screen at 15 weeks 6 days gestation
in a 28 year old woman showed elevated hCG (5.09 MoM)
and normal MSAFP (1.64 MoM). At 15 weeks, ultrasound
examination of the pregnancy revealed two normally devel-
oped fetuses, however twin 2B was smaller and showed
oligohydramnious. Twin 2A had a normal placenta while
twin 2B had a cystic placenta that was described as enlarged
with a ‘‘Swiss cheese’’ appearance. Amniocentesis performed
at 19 weeks showed a 46,XY complement in twin 2A and a
46,XX complement in twin 2B. Amniotic fluid AFP was
normal in both twins. Twin 2B lagged slightly behind in
growth based on ultrasound estimates. Induction, because of
intrauterine growth restriction in twin 2B, was performed at
37 weeks. Twin 2A was a normal boy with APGAR score of 10
and 10, birth weight of 2942 g, head circumference 340 mm,
and length 46 cm. Twin 2B was a normal girl, born by breech
extraction with APGAR score 10 and 10, birth weight of
2210 g (,5%ile), head circumference 310 mm, length 43 cm,
Hb 162 g/l. She was readmitted to the hospital on day 6 for
observation due to a short episode of bradycardia noticed on
a routine home follow up visit, and was monitored for 48 h.
The assessment was normal as were the ECG and echocar-
diogram. This baby is now 3 months of age and clinical
follow up has remained normal with some catch up in
growth.
Examination of the placenta in case 2 showed a dichorionic
twin placenta with fused placental discs, together weighing
690 g. Approximately 60% of the fetal surface was associated
with twin 2B. The placenta for twin 2A was grossly and
histologically normal. The placenta for twin 2B was grossly
abnormal with abnormal chorionic vessels that were large,
dilated, and had a tortuous course (supplementary figure 1).
There were thrombi in the dilated subchorionic vessels.
Grossly, there were some cysts that, histologically, were in
stem villi. The stem villi had abundant myxoid stroma and
oedema with abnormal vessels that extended from the fetal
to maternal surface. The chorionic villi were largely unre-
markable, with only focal hydropic change. There was no
trophoblast hyperplasia. The features were those of PMD.
Cytogenetics
Amniotic fluid samples were cultured, harvested, and GTG
banded according to standard procedures.
CGH
Comparative genomic hybridisation (CGH) was performed on
trophoblast samples following the labelling and hybridisation
protocol detailed previously by Lestou et al.11 DNA extracted
from the trophoblast samples from case 2, twin A and twin B
were each labelled with FITC-12-dUTP and the 46,XX
reference DNA with TRITC-6-dUTP. Diploid metaphase
spreads were obtained from peripheral blood lymphocyte
cultures of a normal male donor by use of standard protocols.
Digital image analysis was performed using a Zeiss Axioplan
epifluorescence microscope with selective filters, a COHU
charge coupled device camera (COHU, San Diego, CA), and
PathVysion Smart Capture VP software (Vysis, Downers
Grove, IL) as described in Lomax et al.12 A shift in the average
red-to-green ratio value above 1.1 or below 0.9 (excluding
known heterochromatic and polymorphic regions) is con-
sidered to be evidence for a dosage difference.
FISH
Fluorescence in situ hybridisation (FISH) studies were
performed on the mesenchyme-1 sample from case 2, twin
B as described by Henderson.32 A probe specific for the alpha
satellite region of chromosome 4 was used (CEP4, Vysis). A
total of 500 nuclei were scored and cut offs for significant
levels of trisomy were taken from tissue matched diploid
controls as described by Lomax et al.12
Molecular investigation
Placental samples were taken from the fetal side of the
placenta, and the amnion and chorionic plate were isolated
from the remaining villi and thoroughly washed with saline
solution. The remaining chorionic villi were subjected to
treatment with collagenase IA (350 U/mg; Sigma, St Louis,
MO) to separate the chorionic villus mesenchyme (mostly
stromal core) from the trophoblast. A sample from one of the
enlarged chorionic vessels was also taken from case 2B. DNA
was extracted from each sample using a salting out method.
PCR amplification was performed using standard condi-
tions with primer pairs for microsatellite markers for
chromosomes 7, 9, 12, 14, 16, and X. Most markers were
genotyped using fluorescently labelled primers with PCR
products quantified on an ABI 310 Prism Genetic Analyzer
(ABI, Foster City, CA). The PCR products for the markers
D9S286, D9S157, D9S162, D9S165, D9S152, and D9S176
were resolved on a polyacrylamide gel and the relative dosage
of parental alleles was estimated following silver staining (for
example, allele ratios were scored as approximately equal,
clear excess of paternal peak, or extreme excess of paternal
peak). Linearity of amplification was demonstrated for AR13
and D7S691 (data not shown) by mixing samples in different
ratios (ranging from 1:9 to 9:1). Allele ratios using multiple
markers consistently showed excess of paternal alleles in the
same tissues. Peak areas for D7S691 were used to estimate
the proportion of the androgenetic cell line, as this marker
was informative in both cases, clearly amplified distinct
alleles, and showed no evidence of an allele amplification
bias. The estimated frequency of the androgenetic cell line
(fAnd) was calculated as: fAnd = Pp2Pm, where Pp and Pm
represent the fractions of the total peak area contributed by
the paternal and maternal peaks, respectively.
RESULTS
Cytogenetic analysis of amniotic fluid obtained in the second
trimester of pregnancy of case 1 twin A revealed two different
diploid female cell populations that could be distinguished
based on a structural polymorphism in the proximal long arm
of chromosome 9 (fig 1A). In half of the cells, both
chromosome 9 homologues contained a large heterochro-
matic region (LL), while in the remaining cells, one large and
one small heterochromatic region (LS) was seen. As twin B
and the mother exhibited an ‘‘SS’’ genotype, and only the
father showed an ‘‘LS’’ genotype for this chromosome 9
polymorphism, the ‘‘LL’’ cell line was inferred to represent
paternal uniparental disomy for chromosome 9. The presence
of the LL cells was confirmed postnatally in chorionic villus
cultures (stromal cells) from two separate placental biopsies,
with the LL genotype observed in 20/20 and 25/30 cells,
respectively.
DNA molecular testing of eight different loci spanning
chromosome 9 was performed on cord blood and placental
samples from case 1 and confirmed an excess of paternal
alleles in the chorion and stroma, consistent with the
presence of mosaicism for paternal uniparental isodisomy
(UPiD) for chromosome 9 (table 1). However, the analysis of
additional markers from other chromosomes also showed
excess dosage of all paternal alleles, suggesting a paternal
UPiD for all chromosomes, not only chromosome 9, in the LL
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lineage (table 1 and supplementary table 1). Thus the LL cells
appeared to be derived exclusively from diploidisation of a
single haploid paternal complement. The same haploid
paternal complement of this androgenetic cell population
also appeared to be present in the normal LS cells with
biparental marker inheritance. The excess dosage of paternal
alleles was not observed in DNA extracted from cord blood or
two trophoblast biopsies in this case (fig 2).
Amniocentesis results for case 2, twin A and twin B were
normal (46,XY and 46, XX, respectively), as was CGH testing
on a trophoblast sample taken from each placenta to rule out
trisomy mosaicism. However, microsatellite loci tested from
chromosomes 7, 9, 12, 16, and X all showed excess of
paternal alleles in samples of chorion, an enlarged chorionic
vessel, and chorionic villus mesenchyme from twin B (fig 1B,





















Figure 1 (A) Partial karyotypes from case 1 consistent with upd(9)pat. The paternal chromosome 9 homologues can be distinguished from each other
based on the length of the polymorphic region directly beneath the centromere. The father has one large and one small chromosome 9, or an ‘‘LS’’
genotype. Both the mother and twin B have two small 9 homologues or an ‘‘SS’’ genotype. Two cell populations were seen in twin A, one with two large
paternally inherited chromosome 9s (LL) and one with both a large paternal and small maternal chromosome 9 (LS). (B) Excess of paternal alleles is
seen for case 2, twin B. Molecular analysis of the microsatellite markers D12S87 (left) and D7S691 (right) for (from top to bottom): maternal blood, twin
A cord, twin B cord, twin B chorion membrane site no. 2, twin B chorionic vessel site no. 2, twin B trophoblast site no. 1, and twin B chorionic villus
mesenchyme site no. 1. A reduced peak size for the maternal alleles is apparent in chorion membrane, vessel, and mesenchyme. Quantification of
allele peaks suggests that the trophoblast sample also shows a slight reduction (1.14:1 paternal:maternal ratio for D7S691 and 1.12:1 for D12S87) in
the maternal peak.
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chorionic vessel samples, for which the maternal allele was
barely detectable. Quantification of marker allelic ratios
suggests that the androgenetic cells may have been present
at very low levels within the trophoblast and amnion. Higher
levels of the androgenetic cells were seen in other extra-
embryonic tissues (fig 2). FISH using a chromosome 4 probe
was within the range expected for normal diploid tissue, thus
excluding ploidy mosaicism as an explanation for the excess
dosage of paternal alleles, and suggests the presence of an
androgenetic diploid cell population.
DISCUSSION
The mechanism of androgenetic/biparental mosaicism in the
two cases presented here appears to have involved only a
single egg and sperm nucleus, as is true for a similar case
diagnosed as a CHM and a ‘‘parthenogenetic chimera’’
(gynogenetic/biparental mosaic, by our terminology) pre-
viously reported.14 15 Chimerism is excluded because the same
haploid paternal complement contributed to both cell
lineages. The simplest explanation would involve failure of
replication of the maternal genome prior to the first cleavage,
with normal replication and segregation of the paternal
genome (fig 3). If the maternal chromosomes did not migrate
to the metaphase plate due to delayed/failed breakdown of
the pronuclear envelope, they would remain together in one
daughter cell. Such a failed division would produce a diploid/
haploid mosaic embryo, as is observed in 1–2% of human
preimplantation embryos.16 17 This is analogous to the
observed mechanism for formation of diploid/haploid
embryos in mouse after delayed sperm incorporation into
the oocyte.18 Endoreduplication of the haploid paternal-only
daughter cell could then occur to produce the diploid
androgenetic lineage, while the female and male haploid
complements would merge to form a daughter cell with
normal biparental inheritance. Origin via fertilisation by a
homozygous diploid sperm seems unlikely since there are no
reports of triploidy arising in this manner.19
As both cases were found to involve the same mechanism,
androgenetic/biparental mosaicism is likely a common cause
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Figure 2 Distribution of androgenetic cells within each placenta. The estimated proportion of androgenetic cells is given for tissues isolated from two
separate biopsy sites from case 1 and four biopsy sites from case 2. This proportion is estimated from the allele peak ratios for markers for D7S691,
which was informative in both cases, had clearly separated bands and no evidence for allelic amplification bias. Only those samples with an estimate of
,10% androgenetic cells (case 2: amnion 2, amnion 3, and trophoblast 1) did not show a consistent bias with all tested markers. The frequency of the
‘‘LL’’ genotype from cultured cells is used for the estimates in the amniotic fluid and stroma samples for case 1. AF, amniotic fluid; AMN, amnion; CB,
cord blood; CHR, chorionic membrane; MES, chorionic mesenchyme; STR, stroma, derived from cultured chorionic villi; TRP, trophoblast; VES,
enlarged chorionic vessel.
















D2S237 ab nt ad ad/dd cd
D6S260 bd cd ad ad/aa ac
D7S691 ac nt bc bc/bb bb
D9S286 bd ab bc bc/cc ac
D9S257 ab bb bc bc/cc bc
D9S162 bb bb ab ab/aa ab
D9S304 bc bb ac ac/aa ab
D9S165 cc ac (b)c (b)c ab
D9S1788 bb bc ab ab/aa ac
D9S152 ac ab ab ab/bb bb
D9S176 ac bc bc bc/bb bc
D12S87 bc ac bb bb ab
D14S161 ab ab ab ab/bb bb
AR NT NT ab ab/bb NT
(b)c indicates the maternal ‘‘c’’ allele is more intense than the ‘‘b’’ allele.
This apparent excess is attributed to poor amplification of the paternal
allele as the flanking markers (D9S304 and D9S1788) are at 0 cM on
either side of D9S165 and do not show this pattern. nt, not tested.
The letters indicate the genotype inferred by allelic dosage. Results
obtained from additional placental samples from twin 1A were identical
to those obtained in cord. Two separate trophoblast and mesenchyme
samples showed similar results (fig 2). NT, not tested.
















D7S691 ab ac bc bc/cc cc
D7S976 ab aa aa aa aa
D9S1788 bc bd ac ac/aa aa
D9S257 ab ac ac ac/cc cc
D12S87 ab bc ac ac/cc cc
D16S409 ac cc bc bc/bb bb
D16S515 aa aa ab ab/bb bb
D16S3093 ab ac ac ac/cc cc
AR bc nt ab ab/aa nt
DXYS233 ac ad bc bc/bb nt
*The maternal allele was visible but very faint; nt, not tested.
The letters indicate the genotype as judged by allelic dosage. Additional
placental samples from twin A yielded results that were identical to those
obtained in cord from twin A; four sites from twin 2B placenta were
sampled. The amnion, chorion, chorionic vessel, mesenchyme, and
trophoblast from the four sampled sites all had similar findings, but with
some variability in allelic ratios (fig 2).
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preponderance of reported cases. If the androgenetic cell line
has arisen by duplication of a haploid paternal genome, as in
the two cases described here, then one would expect only
females to be observed, since a 46,YY cell line would be non-
viable. The rare cases of PMD with a 46,XY genotype could
arise by chimerism (fusion) of a normal embryo with a CHM
derived from a diploid sperm or dispermy in early gestation.
Interestingly, several reported cases of PMD had a coexisting
twin CHM.9 The fact that both of the present cases were
associated with normal dizygotic twins is probably coin-
cidence, as most cases of PMD reported in the literature occur
in singleton pregnancies and those that were associated with
normal twins do not seem to differ in outcome.5–9 Furthermore,
an additional case of androgenetic mosaicism was reported in
an otherwise normal singleton pregnancy, although the
placental findings were reported as that of a CHM and distinct
from PMD.14 The phenotype of androgenetic mosaicism can
presumably range from mild PMD, which may not even be
diagnosed, to typical findings of a CHM, depending on the
extent and distribution of the androgenetic lineage.
Interestingly, features of BWS are frequently reported in
the fetus of pregnancies diagnosed with PMD.6 8 9 Case 1
presented here had liver cysts, the nature of which was not
determined. BWS patients can develop hepatic tumours, and
hepatic mesenchymal hamartoma leading to fetal death has
been reported in conjunction with PMD in several
instances.20 21 It is possible that loss of imprinting of the
11p15.5 genes alone could lead to PMD in some cases,
particularly as a mouse model for BWS incorporating a null
mutation for Cdkn1c/p57Kip2 and loss of Igf2 imprinting shows
some placental abnormalities similar to those found in PMD,
including a large placenta, disorganised labyrinthine layer
(comparable to chorionic villi in humans), and fibrin cysts
with accumulation of red blood cells.23 Alternatively, some
cases of BWS may result from the presence of androgenetic
cells in the fetal tissues and contribute to the 10–20% of BWS
in which no abnormality is found.22
Comparison of these two human androgenetic mosaics to
androgenetic mouse chimeras shows both similarities and
differences. Mice chimeras artificially generated by aggregat-
ing normal and androgenetic blastomeres can lead to
embryos that survive to term, but with differing phenotypes
depending on the level of contribution and distribution of the
uniparental cells.24–26 While competing with normal cells in
chimeras, the androgenetic cells tend to contribute to the
trophectoderm derived tissue of the placenta and to the yolk
sac, but rarely to the chorionic mesoderm, amnion, or embryo
proper.24 25 Chimeras in which androgenetic cells are found in
the embryo proper rarely survive, and those that do have
exhibited skeletal anomalies.26
As with the mouse chimeras, the androgenetic cells
detected in the human cases described here were predomi-
nantly confined to the placenta. However, the androgenetic
cells tended not to be present in the trophoblast and instead
were confined predominantly to chorionic mesoderm, mem-
brane, and vessels. In case 1A, androgenetic cells were
observed in amniotic fluid and abnormal pathology was
observed in the liver, suggesting that mosaicism was also
present in the fetus. Similar to mouse androgenetic chimeras,
there is a high intrauterine death rate of fetuses associated
with PMD. However, skeletal anomalies were not identified
in the present cases or in other births that have been
associated with PMD. Any differences in comparison to the
mouse chimeras may reflect differences in imprinting of
genes in humans and mice. For example, the Igf2r, Mash2/
Ascl2, Xist, and Esx1 genes are imprinted in mouse, but the
corresponding human genes are either not imprinted or have
a less clear imprinting status.27–30 There are also clear
differences in expression patterns for some imprinted genes
between mice and humans. For example, Peg3 is expressed in
mouse spongiotrophoblast, secondary giant cells, and the
labyrinth, whereas in humans PEG3 is only expressed in
villus cytotrophoblast and no other placental cells.31
As we evaluated only term placentas, it is possible that
androgenetic cells did contribute to the early, undifferen-
tiated cytotrophoblast but are less able to differentiate and
persist to term in this lineage. The hyper-proliferation of the
villus trophoblast observed in CHMs may be an indirect
Figure 3 Proposed mechanism for the origin of androgenetic/biparental mosaicism. 2n represents a diploid chromosome complement; n represents a
haploid chromosome complement; n1C represents an unreplicated haploid complement; and n2C represents a replicated haploid complement.
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consequence of failure of these cells to differentiate down
other pathways due to lack of key maternally expressed
genes. In the androgenetic mosaics, biparental trophoblast
cells should differentiate normally into invasive trophoblast
or undergo fusion into syncytiotrophoblast. The presence of
these normally differentiated trophoblast subtypes may
provide appropriate feedback signals to the undifferentiated
villus cytotrophoblast that prevent further uncontrolled
growth. A term placenta consists of few undifferentiated
cytotrophoblast cells and thus would be expected to consist
predominantly of mature trophoblast with a biparental
genome in this scenario.
The observation that androgenetic cells can arise sponta-
neously and persist in viable human pregnancies is intriguing
and raises many questions. It remains to be determined if this
is the mechanism for all cases of PMD or if the aetiology of
PMD is heterogeneous. Androgenetic mosaicism could also
lead to miscarriage in some pregnancies, as one would only
expect cases with relatively low levels of androgenetic cells to
survive into late gestation. It may also contribute to
unexplained isolated intrauterine growth restriction (as in
case 2), as the placental features may not always be obvious
or diagnosed. In addition to the clinical implications, these
pregnancies offer a rare opportunity to study imprinted gene
expression and developmental potential of androgenetic cells
existing in viable pregnancies. The ability to diagnose PMD in
utero, based on the unusual findings of a cystic placenta with
a normal viable fetus, will facilitate further characterisation
of this developmental disorder linking a specific placental
dysplasia with androgenetic mosaicism and the functions of
imprinted genes in human development.
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